Innovation and austerity: How can the NHS prioritise, afford and deliver innovation?

This timely seminar brought together 20 senior leaders from the health and social care system. The recently published interim report of the AAR provided a topical backdrop for discussions, and Sir Hugh Taylor, Chair of the AAR expert advisory group was in attendance to generate further recommendations for the report.

Conference/Seminar

Start date: 18/01/2016 | 8:30

End date: 18/01/2016 | 10:30

For more information on this conference contact:

020 7631 8450

Historically the UK has a strong track record of delivering innovations with great impact on healthcare globally, but the NHS has struggled to adopt innovation and best practice at pace and scale. The next five year period is one of the most challenging ever for the NHS as it faces a predicted funding shortfall of £30bn by 2020, coupled with rising demand for services.

Technology and innovation are vital to close the gap between rising demand and financial strain, ensuring the NHS achieves better outcomes for patients whilst maintaining quality at a lower cost. The NHS has been considering how best to adopt and diffuse innovation for some time, with Innovation Health and Wealth and latterly with the Accelerated Access Review (AAR).

The NHS Five Year Forward View encourages more innovation in the models of health and social care delivery to improve quality of care, outcomes and reduce costs. Therefore, it is now more important than ever to think about how the NHS can prioritise, afford and deliver innovation in order to design a future healthcare system that is fit for purpose.

This timely seminar brought together 20 senior leaders from the health and social care system. The recently published interim report of the AAR provided a topical backdrop for discussions, and Sir Hugh Taylor, Chair of the AAR expert advisory group was in attendance to generate further recommendations for the report. In particular the seminar covered:

  • What are the barriers and enablers to adoption and diffusion of innovation?
  • How can innovation be prioritised and rewarded in the system? How do we better align incentives?
  • How can innovation meet the needs of rising patient and system demands?
  • What levers locally and nationally can be used to promote uptake of innovation?
  • How do we get the system working better together to ensure innovation is fostered in an optimum way?
  • What role should Academic Health Science Networks play?
  • What difference will the AAR proposals for a national Innovation Partnership and local Innovation Exchanges make?

This seminar was organised, and associated material produced, by the Nuffield Trust in collaboration with MSD, and MSD provided funding. 

Chair

Partners

MSD